Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    " July 29, 2009":" August 28, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" July 29, 2009":" August 28, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy
Conditions: HIV;   HIV Infections
Intervention: Behavioral: pharmaceutical care
2 Enrolling by invitation Internet-based HIV/STI Prevention for Young MSM Receiving HIV Testing
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Keep It Up!;   Behavioral: Information only
3 Withdrawn Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts
Conditions: HIV Infection;   AIDS;   HIV Infections
4 Completed
Has Results
Statin Therapy to Improve Atherosclerosis in HIV Patients
Conditions: Cardiovascular Disease;   HIV;   Atherosclerosis;   Inflammation;   Statins, HMG-CoA;   HIV Infections
Interventions: Drug: atorvastatin;   Drug: Placebo
5 Completed Study to Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection - A Positron Emission Tomography (PET) Study
Conditions: Acute Hepatitis C;   HIV;   HIV Infections
6 Completed Human Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CT
Conditions: Insulin Resistance;   Atherosclerosis;   Cardiovascular Disease;   HIV/AIDS;   HIV Infections
7 Unknown  Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
Conditions: HIV Transmission;   HIV Infections
Intervention: Drug: tenofovir + emtricitabine, lopinavir/ritonavir
8 Completed
Has Results
Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection
Condition: HIV Infections
Interventions: Drug: Etravirine (Intelence);   Drug: Truvada
9 Completed Molecular Biology of Anal Cancer in HIV-Positive Patients
Conditions: Carcinoma;   HIV Infections
10 Completed Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults
Condition: HIV Infections
Interventions: Biological: NYVAC-B;   Biological: Placebo;   Biological: rAd5
11 Completed Feasibility Study of a Multi-Component Intervention for Black Men Who Have Sex With Men
Condition: HIV Infections
Interventions: Behavioral: Referral of Partners;   Behavioral: Screening for STIs and counseling;   Behavioral: Peer health care system navigators;   Behavioral: Enhanced counseling
12 Active, not recruiting Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP;   Biological: VRCHIVADV014-00-VP
13 Completed
Has Results
A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)
Conditions: HIV Infections;   Hepatitis C;   HCV Infection
Interventions: Drug: PegIFN-2b;   Drug: RBV;   Drug: Placebo to Boceprevir;   Drug: Boceprevir
14 Unknown  Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)
Condition: HIV Infections
Intervention: Drug: Adaptavir (monomeric DAPTA)
15 Completed IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women
Condition: HIV Infection
Intervention: Drug: Highly active antiretroviral therapy (HAART)
16 Completed Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)
Condition: HIV Infections
Interventions: Drug: fosamprenavir/ritonavir;   Drug: olanzapine
17 Unknown  Reducing HIV Risks in African American Teens
Condition: HIV Infections
Intervention: Behavioral: Healthy Futures parent education
18 Completed Evaluating the Pharmacokinetics of 400 mg Oral Dose of Raltegravir in HIV-Infected Pre-Menopausal Women
Condition: HIV Infections
19 Completed Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects
Conditions: HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: control group
20 Completed Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Conditions: HIV;   Depression;   HIV Infections
Interventions: Behavioral: Cognitive behavioral therapy (CBT) for adherence and depression (CBT-AD);   Behavioral: Life-steps adherence treatment;   Behavioral: Information and supportive psychotherapy (ISP) for adherence and depression (ISP-AD)

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years